These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18311780)

  • 21. WRN loss induces switching of telomerase-independent mechanisms of telomere elongation.
    Gocha AR; Acharya S; Groden J
    PLoS One; 2014; 9(4):e93991. PubMed ID: 24709898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
    Fasching CL; Bower K; Reddel RR
    Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression.
    Costa A; Daidone MG; Daprai L; Villa R; Cantù S; Pilotti S; Mariani L; Gronchi A; Henson JD; Reddel RR; Zaffaroni N
    Cancer Res; 2006 Sep; 66(17):8918-24. PubMed ID: 16951210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
    Perrem K; Colgin LM; Neumann AA; Yeager TR; Reddel RR
    Mol Cell Biol; 2001 Jun; 21(12):3862-75. PubMed ID: 11359895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The telomere-associated homeobox-containing protein TAH1/HMBOX1 participates in telomere maintenance in ALT cells.
    Feng X; Luo Z; Jiang S; Li F; Han X; Hu Y; Wang D; Zhao Y; Ma W; Liu D; Huang J; Songyang Z
    J Cell Sci; 2013 Sep; 126(Pt 17):3982-9. PubMed ID: 23813958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomere recombination requires the MUS81 endonuclease.
    Zeng S; Xiang T; Pandita TK; Gonzalez-Suarez I; Gonzalo S; Harris CC; Yang Q
    Nat Cell Biol; 2009 May; 11(5):616-23. PubMed ID: 19363487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. hRad21 overexpresses and localizes to the ALT-associated promyelocytic leukemia body in ALT cells.
    Zhao B; Wang ZJ; Yi BQ; Ma HC; Xu HM
    Cancer Biol Ther; 2010 Jun; 9(12):978-83. PubMed ID: 20364118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of hRad9, hHus1, hRad1, and hRad17 and caffeine-sensitive DNA replication at the alternative lengthening of telomeres-associated promyelocytic leukemia body.
    Nabetani A; Yokoyama O; Ishikawa F
    J Biol Chem; 2004 Jun; 279(24):25849-57. PubMed ID: 15075340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
    Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topoisomerase IIIalpha is required for normal proliferation and telomere stability in alternative lengthening of telomeres.
    Temime-Smaali N; Guittat L; Wenner T; Bayart E; Douarre C; Gomez D; Giraud-Panis MJ; Londono-Vallejo A; Gilson E; Amor-Guéret M; Riou JF
    EMBO J; 2008 May; 27(10):1513-24. PubMed ID: 18418389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PML3 interacts with TRF1 and is essential for ALT-associated PML bodies assembly in U2OS cells.
    Yu J; Lan J; Wang C; Wu Q; Zhu Y; Lai X; Sun J; Jin C; Huang H
    Cancer Lett; 2010 May; 291(2):177-86. PubMed ID: 19900757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and cellular evidence for the alternative lengthening of telomeres (ALT) mechanism in chicken.
    O'Hare TH; Delany ME
    Cytogenet Genome Res; 2011; 135(1):65-78. PubMed ID: 21822009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT).
    Falcinelli M; Dell'Omo G; Grassi E; Mariella E; Leto SM; Scardellato S; Lorenzato A; Arena S; Bertotti A; Trusolino L; Bardelli A; d'Adda di Fagagna F
    Cell Death Dis; 2023 Feb; 14(2):96. PubMed ID: 36759506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
    Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A
    J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SLX4IP N-terminus dictates telomeric localization in ALT-like castration-resistant prostate cancer cell lines.
    Mangosh TL; Grabowska MM; Taylor DJ
    Prostate; 2021 Nov; 81(15):1235-1251. PubMed ID: 34492133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapies.
    Gocha AR; Nuovo G; Iwenofu OH; Groden J
    Am J Pathol; 2013 Jan; 182(1):41-8. PubMed ID: 23260199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [ALT--alternative lengthening of telomere].
    Wu XM; Tang WR; Luo Y
    Yi Chuan; 2009 Dec; 31(12):1185-91. PubMed ID: 20042385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The first molecular details of ALT in human tumor cells.
    Muntoni A; Reddel RR
    Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R191-6. PubMed ID: 16244317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomere length heterogeneity in ALT cells is maintained by PML-dependent localization of the BTR complex to telomeres.
    Loe TK; Li JSZ; Zhang Y; Azeroglu B; Boddy MN; Denchi EL
    Genes Dev; 2020 May; 34(9-10):650-662. PubMed ID: 32217664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The roles of WRN and BLM RecQ helicases in the Alternative Lengthening of Telomeres.
    Mendez-Bermudez A; Hidalgo-Bravo A; Cotton VE; Gravani A; Jeyapalan JN; Royle NJ
    Nucleic Acids Res; 2012 Nov; 40(21):10809-20. PubMed ID: 22989712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.